首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

DNA合成市場規模、佔有率和成長分析（按產品、類型、方法、應用、最終用戶和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1898333

DNA合成市場規模、佔有率和成長分析（按產品、類型、方法、應用、最終用戶和地區分類）—產業預測，2026-2033年

DNA Synthesis Market Size, Share, and Growth Analysis, By Product (Instruments, Reagents & Consumables), By Type (Oligonucleotide Synthesis, Gene Synthesis), By Method, By Application, By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，DNA 合成市場價值將達到 53.1 億美元，到 2025 年將成長至 61.9 億美元，到 2033 年將成長至 210 億美元，在預測期（2026-2033 年）內複合年成長率為 16.5%。

在製藥、生物技術和基因研究等關鍵應用領域的推動下，DNA合成市場正經歷強勁成長。生物技術公司和研究人員越來越依賴DNA合成服務來創建客製化的DNA序列，用於藥物開發和基因工程等領域。推動市場擴張的關鍵因素包括合成生物學工具需求的成長、個人化醫療的蓬勃發展以及基因編輯技術的持續進步。此外，DNA合成能夠實現快速原型製作和實驗，從而促進創新並加速科學發現。隨著生物技術和醫療保健產業的進步，DNA合成有望在基因組學和分子生物學的發展中發揮關鍵作用，並影響這些領域的未來發展。

DNA合成市場促進因素

推動DNA合成市場成長的關鍵因素是基因工程技術的不斷進步。 CRISPR-Cas9等創新技術以及各種基因編輯技術顯著提升了對客製化DNA序列的需求。這種需求的激增源於研究人員和生物技術公司對用於實驗和應用的精準、特化的DNA構建體的需求，這使得DNA合成成為開創性基因工程舉措的重要組成部分。隨著這些先進技術的不斷發展，預計各科學領域對客製化DNA合成服務的需求將進一步成長。

限制DNA合成市場的因素

影響DNA合成市場的關鍵阻礙因素是監管遺傳物質合成和應用的嚴格法律體制。與基因編輯和生物技術相關的嚴格監管機制可能會阻礙市場准入，並阻礙研發。雖然這些法規對於確保行業內的道德規範和安全至關重要，但它們也可能給該領域的公司帶來挑戰。因此，遵守這些嚴格標準的要求可能會減緩創新，並限制DNA合成公司的成長潛力。

DNA合成市場趨勢

在基因編輯技術的不斷進步推動下，DNA合成市場正經歷蓬勃發展，CRISPR-Cas9等工具的出現正在徹底改變這個產業。這項進步顯著提升了對客製化DNA序列的需求，而客製化DNA序列對於從治療方法創新到農業改良等各種應用領域中的精準基因修飾至關重要。隨著這些基因編輯解決方案變得更加普及和靈活，它們不僅促進了突破性研究，也正在塑造生物技術的未來。因此，DNA合成市場預計將保持強勁成長，並有望有效滿足研究人員和生技公司在尋求變革性解決方案方面不斷變化的需求。

Thermo Fisher Scientific（USA）
Twist Bioscience（USA）
BIONEER Corporation（South Korea）
Eton Bioscience, Inc.（USA）
LGC Biosearch Technologies（UK）
IBA Lifesciences GmbH（Germany）
Eurofins Scientific（Luxembourg）
Integrated DNA Technologies, Inc.（USA）
Quintara Biosciences（USA）
GenScript（China）
Bio Basic Inc.（Canada）
OriGene Technologies, Inc.（USA）
Synbio Technologies（USA）
GeneArt（Germany）
Genewiz（USA）
Sangon Biotech（China）
Creative Biogene（USA）
BaseClear BV（Netherlands）
BioCat GmbH（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35H2185

DNA Synthesis Market size was valued at USD 5.31 Billion in 2024 and is poised to grow from USD 6.19 Billion in 2025 to USD 21 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026-2033).

The DNA synthesis market is witnessing robust growth, largely fueled by its essential applications in pharmaceuticals, biotechnology, and genetic research. Biotech companies and researchers are increasingly turning to DNA synthesis services to create customized DNA sequences applicable in areas such as drug development and genetic engineering. Key drivers of this market's expansion include the rising need for tools in synthetic biology, the surge in personalized medicine, and ongoing advancements in gene editing technologies. Furthermore, DNA synthesis facilitates rapid prototyping and experimentation, which enhances innovation and accelerates scientific discovery. As the fields of biotechnology and healthcare progress, DNA synthesis is set to play a crucial role in advancing genomics and molecular biology, influencing future developments in these sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the DNA Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

DNA Synthesis Market Segments Analysis

Global DNA Synthesis Market is segmented by Product, Type, Method, Application, End-user and region. Based on Product, the market is segmented into Instruments, Reagents & Consumables and Services. Based on Type, the market is segmented into Oligonucleotide Synthesis and Gene Synthesis. Based on Method, the market is segmented into Solid-phase Synthesis, PCR-based Enzyme Synthesis and Chip-based Synthesis. Based on Application, the market is segmented into Diagnostics, Therapeutics and Research & Development. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the DNA Synthesis Market

A primary catalyst for the growth of the DNA synthesis market is the ongoing progress in genetic engineering technologies. Innovations such as CRISPR-Cas9 and various gene-editing methodologies have greatly heightened the need for custom DNA sequences. This surge in demand stems from researchers and biotechnology companies seeking accurate and specialized DNA constructs for their experiments and applications, positioning DNA synthesis as an essential element in pioneering genetic engineering initiatives. As these sophisticated technologies continue to evolve, they are expected to further propel the necessity for bespoke DNA synthesis services across diverse scientific fields.

Restraints in the DNA Synthesis Market

A significant constraint affecting the DNA synthesis market is the rigorous regulatory framework governing the synthesis and application of genetic materials. The strict oversight related to gene editing and biotechnology can hinder market accessibility and impede research and development initiatives. While these regulations are crucial for ensuring ethical practices and safety within the industry, they can also present challenges for companies operating in this sector. As a result, the necessity of complying with these stringent standards may delay innovation and restrict the growth potential of businesses involved in DNA synthesis.

Market Trends of the DNA Synthesis Market

The DNA synthesis market is experiencing a dynamic trend fueled by ongoing advancements in gene editing technologies, with tools like CRISPR-Cas9 revolutionizing the landscape. This progress is significantly increasing the demand for customized DNA sequences, essential for precise genetic modifications across diverse applications, from therapeutic innovations to agricultural enhancements. As these gene editing solutions become more accessible and adaptable, they are not only inspiring groundbreaking research but also shaping the future of biotechnology. Consequently, the DNA synthesis market is poised for robust growth, effectively meeting the evolving requirements of researchers and biotech firms striving for transformative solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global DNA Synthesis Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Instruments
Reagents & Consumables
Services

Global DNA Synthesis Market Size by Type & CAGR (2026-2033)

Market Overview
Oligonucleotide Synthesis
Gene Synthesis

Global DNA Synthesis Market Size by Method & CAGR (2026-2033)

Market Overview
Solid-phase Synthesis
PCR-based Enzyme Synthesis
Chip-based Synthesis

Global DNA Synthesis Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostics
- Infectious Diseases
- Cancer
Therapeutics
- Gene Therapy
- Preventive Medicine
Research & Development
- Cloning and Gene Editing
- Drug Discovery & Development

Global DNA Synthesis Market Size by End-user & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)
Academic & Research Institutes

Global DNA Synthesis Market Size & CAGR (2026-2033)

North America (Product & Service, Type, Method, Application, End-user)
- US
- Canada
Europe (Product & Service, Type, Method, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Type, Method, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Type, Method, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Type, Method, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIONEER Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eton Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Biosearch Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Lifesciences GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quintara Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Basic Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synbio Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneArt (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sangon Biotech (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BaseClear B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCat GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments